Cannabis Report
Home > Boards > US Listed > Biotechs >

Novavax (NVAX)

NVAX RSS Feed
Add NVAX Price Alert      Hide Sticky   Hide Intro
Moderator: I Need Money , WovenO2
Search This Board: 
Last Post: 5/23/2018 5:31:29 PM - Followers: 235 - Board type: Free - Posts Today: 0

ABOUT NOVAVAX:

Novavax, Inc. (Nasdaq: NVAX) is a clinical-stage biopharmaceutical company creating recombinant protein nanoparticle vaccines to address a broad range of infectious diseases. The company is developing a portfolio of vaccine candidates targeting seasonal and pandemic influenza (H5N1), a vaccine designed to protect children and the elderly against respiratory syncytial virus (RSV), rabies and other candidates. In addition, the company is developing its vaccine candidates for worldwide commercialization including:

Our world-class scientific team is using VLP technology to tackle influenza viruses – including avian strains that have the potential to cause a pandemic outbreak. Our team has created vaccine candidates that are in various phases of clinical testing designed to protect against various circulating strains of pandemic influenza including H1N1 and H5N1, as well as seasonal influenza. Our recombinant nanoparticle protein micelle technology targeted at RSV has been tested in various preclinical studies and has now advanced into clinical testing.

Our vision is to control the spread of infectious diseases by using a unique single-use manufacturing system that allows for the rapid mass production of recombinant protein nanoparticle vaccines. Our goal is to be able to rapidly deliver a customized vaccine in the midst of a declared pandemic.
 


MANAGEMENT TEAM:

President and Chief Executive Officer
Stanley C. Erck

Senior Vice President, Research and Development
Gregory M. Glenn, M.D.

Senior Vice President, Manufacturing and Process Development
Timothy J. Hahn, Ph.D.

Senior Vice President, Chief Financial Officer and Treasurer
Barclay A. "Buck" Phillips

Senior Vice President, Business Development
Russell P. "Rip" Wilson

Vice President, Regulatory Affairs
Amy B. Fix

Vice President, Chief Medical Officer
Louis F. Fries III, M.D.

Vice President, Manufacturing
Mervyn L. Hamer

Vice President, General Counsel and Corporate Secretary
John A. Herrmann III, J.D.

Vice President, Process Development
Erica Shane, Ph.D.

Vice President, Vaccine Development
Gale Smith, Ph.D.

Vice President, Clinical Operations
D. Nigel Thomas, Ph.D.

 

CLINICAL-STAGE PIPELINE:

Novavax’s clinical program includes vaccine candidates designed to address infectious diseases worldwide. Using innovative virus-like particle (VLP) and recombinant nanoparticle technology, as well as new and efficient manufacturing approaches, the company produces vaccine candidates to combat diseases, with the goal of allowing countries to better prepare for and more effectively respond to rapidly spreading infections. Our clinical pipeline is shown below.

 
ADJUVANT PIPELINE:

 

 
CHARTS:



 


LINKS:

http://www.novavax.com/
http://finance.yahoo.com/q/h?s=NVAX
http://www.novavax.com/download/File/Interphex.pdf
http://www.sec.gov/cgi-bin/browse-edgar?company=Novavax&CIK=&filenum=&State=&SIC=&owner=include&action=getcompany
http://www.wipo.int/pctdb/en/wo.jsp?WO=2008061243

 
Cannabis Report
NVAX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NVAX News: Statement of Changes in Beneficial Ownership (4) 05/15/2018 11:19:32 AM
NVAX News: Statement of Changes in Beneficial Ownership (4) 05/15/2018 11:17:32 AM
NVAX News: Statement of Changes in Beneficial Ownership (4) 05/15/2018 11:14:53 AM
NVAX News: Current Report Filing (8-k) 05/10/2018 04:29:29 PM
NVAX News: Quarterly Report (10-q) 05/09/2018 05:06:53 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#5915   great news! not surprised! the gipper 05/23/18 05:31:29 PM
#5914   Institutional ownership of NVAX is up 21% over senderos 05/22/18 09:25:05 AM
#5913   yup , just a matter of time. Fibanotch 05/18/18 09:55:00 AM
#5912   I have to agree with u there! :) I Need Money 05/17/18 04:42:01 PM
#5911   this is a no brain ore; at 1.75 $ Fibanotch 05/17/18 11:34:36 AM
#5910   * * $NVAX Video Chart 05-15-18 * * ClayTrader 05/15/18 05:06:46 PM
#5909   CEO bought 100K shares bleu22 05/15/18 01:49:09 PM
#5908   "Reaching this enrollment target for the Prepare trial LasNubes 05/07/18 07:34:44 AM
#5907   GAITHERSBURG, Md., May 07, 2018 (GLOBE NEWSWIRE) -- LasNubes 05/07/18 07:33:57 AM
#5906   https://www.washingtonpost.com/news/to-your-health/wp/2018/04/27/bill-gates-call -blklabs- 04/28/18 10:15:07 AM
#5905   "BILL GATES SAYS U.S. SHOULD PREPARE FOR LIKELY -blklabs- 04/27/18 03:50:57 PM
#5904   Thank you blklabs Dgoff 04/25/18 12:24:21 PM
#5903   Believe deals are set through brokers at total -blklabs- 04/25/18 12:18:44 PM
#5902   Anybody on here no the reason why Stan Dgoff 04/25/18 12:01:17 PM
#5901   bleu22, I agree, no bad news except that the gipper 04/24/18 10:34:25 PM
#5900   Just another day in biotech, EXEL did the bleu22 04/24/18 05:03:13 PM
#5899   Stan put it to the shareholders with that the gipper 04/24/18 04:48:32 PM
#5898   Pretty sad Dgoff 04/24/18 02:16:22 PM
#5897   * * $NVAX Video Chart 04-20-18 * * ClayTrader 04/20/18 05:15:27 PM
#5896   Is this news? “Phase" #3 "Diabetes" 7charity 04/20/18 04:55:50 PM
#5895   Agree. Add under 2 if u can I Need Money 04/18/18 09:01:28 AM
#5894   Looks like we raised a chunk of cash: senderos 04/18/18 08:40:56 AM
#5893   Should be getting efficacy news very soon on the gipper 04/18/18 07:16:39 AM
#5892   Looks like a slow recovery underway... $2+ I Need Money 04/17/18 02:31:36 PM
#5891   Yea bleu22 I know you're right. It the gipper 04/17/18 09:22:46 AM
#5890   I agree, but it was obviously big boys bleu22 04/17/18 08:45:39 AM
#5889   Have those shares even sold to market yet? gastric 04/17/18 08:25:55 AM
#5888   Pretty disappointed that Stan placed the offering @ the gipper 04/17/18 07:22:30 AM
#5887   Stabilizing here. Pretty common for clinical trial I Need Money 04/13/18 11:35:45 AM
#5886   dillution will close today,,record transaction,hold tite $$$$$$ kingsransome 04/13/18 08:25:50 AM
#5885   GAITHERSBURG, Md., April 11, 2018 (GLOBE NEWSWIRE) -- bleu22 04/13/18 08:22:17 AM
#5884   The potentially massive dilution comming? If they need gastric 04/13/18 08:00:01 AM
#5883   What do the need saving from? JPL1868 04/13/18 06:32:51 AM
#5882   Could a buy out at this point save nvax Dgoff 04/13/18 06:16:27 AM
#5881   Gay trader is back, LOL, short restriction tomorrow bleu22 04/12/18 07:15:06 PM
#5880   * * $NVAX Video Chart 04-12-18 * * ClayTrader 04/12/18 04:23:03 PM
#5879   I see it as a great buying opportunity LasNubes 04/12/18 07:06:28 AM
#5878   I got sooo lucky because of your comment, WovenO2 04/11/18 10:40:57 PM
#5877   Well that sure kills April calls. Funny how -blklabs- 04/11/18 08:48:24 PM
#5876   Answered my own question. New shares to market. https://globenewswire.com/news gastric 04/11/18 05:49:48 PM
#5875   Overreacting to what? gastric 04/11/18 05:46:42 PM
#5874   No, it will drop for a while then underdog150 04/11/18 04:57:01 PM
#5873   Watch and learn stockwinner 04/11/18 04:55:15 PM
#5872   I think it will bounce back and by tabuhasna 04/11/18 04:47:40 PM
#5871   So it can catapult? tabuhasna 04/11/18 04:46:40 PM
#5870   It's more dilution for shareholders. underdog150 04/11/18 04:38:18 PM
#5869   Will bounce back people over reacting stockwinner 04/11/18 04:36:14 PM
#5868   So what is your take on this? tabuhasna 04/11/18 04:33:39 PM
#5867   $$$$$$$ or no? tabuhasna 04/11/18 04:24:06 PM
#5866   Novavax Announces Proposed Public Offering of Common Stock underdog150 04/11/18 04:16:31 PM
PostSubject